31/05/2024  22:10:00 Var. +4.85 Volume Denaro02:00:00 Lettera02:00:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
286.86USD +1.72% 323,901
Fatturato: 48.55 mill.
265.00Quantità in denaro: 100 302.00Quantità in lettera: 100 6.73 bill.USD - -

Descrizione business

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Norman Schwartz
Consiglio di amministrazione
Ilan Daskal, Ajit Ramalingam, Andrew Last, Dara Wright, Mike Crowley, Timothy S. Ernst, Simon May, Diane Dahowski
Consiglio di sorveglianza
Norman Schwartz, Alice N. Schwartz, Arnold Pinkston, Gregory Hinckley, Jeffrey Edwards, Melinda Litherland
 

Dati aziendali

Name: Bio-Rad Laboratories Inc.
Indirizzo: 1000 Alfred Nobel Drive,Hercules, California 94547, USA
Telefono: +1-510-741-7000
Fax: +1-510-741-5817
E-mail: -
Internet: www.bio-rad.com
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 70.50%
Data dell'IPO: 03/03/1980

Rapporti con gli investitori

Name: Edward Chung
IR telefono: +1-510-741-6104
IR Fax: -
IR e-mail: ir@bio-rad.com

Principali azionisti

Altri
 
61.54%
Vanguard Group Inc
 
9.98%
Blackrock Inc.
 
6.57%
Veritas Asset Management LLP
 
4.74%
Brown Advisory Inc.
 
3.86%
State Street Corporation
 
3.75%
Ubs Asset Management Americas Inc
 
2.23%
Alliancebernstein L.P.
 
1.91%
Alliancebernstein L.P.
 
1.88%
Altri
 
3.54%